Nexscient, Inc. Files 8-K
Ticker: NXNT · Form: 8-K · Filed: Feb 3, 2025 · CIK: 1976663
| Field | Detail |
|---|---|
| Company | Nexscient, Inc. (NXNT) |
| Form Type | 8-K |
| Filed Date | Feb 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, sec-filing, regulation-fd
TL;DR
Nexscient filed a routine 8-K, no major news.
AI Summary
Nexscient, Inc. filed an 8-K on February 3, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Nexscient, Inc. is fulfilling its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not disclose any new material information or events that would indicate increased risk.
Key Players & Entities
- Nexscient, Inc. (company) — Registrant
- February 3, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2029 Century Park East, Suite 400 Los Angeles, CA 90067 (address) — Principal executive offices
- (310) 494-6620 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Nexscient, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits, as indicated in the filing details.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on February 3, 2025.
In which state is Nexscient, Inc. incorporated?
Nexscient, Inc. is incorporated in Delaware.
What is the principal executive office address for Nexscient, Inc.?
The principal executive office address for Nexscient, Inc. is 2029 Century Park East, Suite 400, Los Angeles, CA 90067.
Does this filing disclose any specific financial results or material events?
Based on the provided text, this filing does not disclose specific financial results or material events beyond the standard reporting categories of Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Stats: 548 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-02-03 13:21:43
Filing Documents
- nexscient_8k.htm (8-K) — 22KB
- nexscient_ex991.htm (EX-99.1) — 12KB
- 0001477932-25-000639.txt ( ) — 154KB
- nexscient-20250203.xsd (EX-101.SCH) — 6KB
- nexscient-20250203_lab.xml (EX-101.LAB) — 13KB
- nexscient-20250203_cal.xml (EX-101.CAL) — 1KB
- nexscient-20250203_pre.xml (EX-101.PRE) — 8KB
- nexscient-20250203_def.xml (EX-101.DEF) — 2KB
- nexscient_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On February 3, 2025, Nexscient, Inc. (the "Company") announced the formation of NXNT Labs, its business unit focused on fast-tracking the commercialization and deployment of innovative and AI-driven products and services. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in the Report under Item 7.01 and Exhibit 99.1 attached hereto will not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific referencing in such filing. The furnishing of the information in Item 7.01 of this report and the press release is not intended to, and does not, constitute a determination or admission by the Company that such information is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 99.1 Press release dated February 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NEXSCIENT, INC. Date: February 3, 2025 By: /s/ Fred E. Tannous Fred E. Tannous President & Chief Executive Officer 3